[Sites of action of Vinca-alcaloids in protein and nucleic acid metabolism of leukemic lymphocytes in vitro. 2].
D000818:Animals; D001798:Blood Proteins / Q000096:biosynthesis*; D002247:Carbon Isotopes; D002417:Cattle; D002418:Cattle Diseases / Q000188:drug therapy*; D004254:DNA Nucleotidyltransferases / Q000097:blood*; D003864:Depression, Chemical; D006651:Histocytochemistry; D007938:Leukemia / Q000097:blood* / Q000188:drug therapy / Q000662:veterinary*; D008214:Lymphocytes / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D010770:Phosphotransferases / Q000097:blood*; D012316:RNA Nucleotidyltransferases / Q000097:blood*; D013936:Thymidine; D014500:Uracil Nucleotides; D014529:Uridine; D014747:Vinblastine / Q000494:pharmacology* / Q000627:therapeutic use; D014750:Vincristine / Q000494:pharmacology* / Q000627:therapeutic use
D001798:Blood Proteins; D002247:Carbon Isotopes; D014500:Uracil Nucleotides; D014750:Vincristine; D014747:Vinblastine; D010770:Phosphotransferases; D004254:DNA Nucleotidyltransferases; D012316:RNA Nucleotidyltransferases; D013936:Thymidine; D014529:Uridine
Angriffspunkte von Vinca-Alkaloiden im Protein- und Nucleinsäurestoffwechsel leukämischer Rinderlymphocyten in vitro. 2.